ArticleFrontiers in immunology2022

Human ILC3 Exert TRAIL-Mediated Cytotoxicity Towards Cancer Cells.

Jana-Julia Siegler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.